Macasasa, Arlene S.

HRN: 26-91-50  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/10/2025
08/16/2025
IV
1.5g
Q8
Infected Wound
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines